The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fishman Corey N. since 2018.
This trader's CIK number is 1553594.
At the time of last reporting, Fishman Corey N. was the Chief Executive Officer of Iterum Therapeutics Plc. (stock ticker symbol ITRM).
Also see all insider trading activities at Iterum Therapeutics Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | MNTA | 0 | $0 | 0 | $0 | 4,356 | $0 |
| 2018 | MNTA | 0 | $0 | 0 | $0 | 5,734 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ITRM | 0 | $0 | 0 | $0 | 82,613 | $0 |
| 2023 | ITRM | 10,000 | $15,860 | 0 | $0 | 0 | $0 |
| 2022 | ITRM | 0 | $0 | 0 | $0 | 215,000 | $0 |
| 2021 | ITRM | 0 | $0 | 85,445 | $147,819 | 0 | $0 |
| 2018 | ITRM | 5,000 | $56,466 | 0 | $0 | 0 | $0 |
1. Momenta Pharmaceuticals Inc (MNTA)
2. Iterum Therapeutics Plc (ITRM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-20 | MNTA | Option Ex | 4,356 | .00 | 0 |
| 2018-06-20 | MNTA | Option Ex | 5,734 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-06 | ITRM | Option Ex | 82,613 | .00 | 0 |
| 2023-11-20 | ITRM | Buy | 10,000 | 1.59 | 15,860 |
| 2022-03-11 | ITRM | Option Ex | 215,000 | .00 | 0 |
| 2021-01-26 | ITRM | Sale | 85,445 | 1.73 | 147,819 |
| 2018-08-17 | ITRM | Buy | 2,000 | 8.73 | 17,466 |
| 2018-05-30 | ITRM | Buy | 3,000 | 13.00 | 39,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fishman Corey N. (Chief Executive Officer of Iterum Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.